Search

Your search keyword '"Glenthoj, Andreas"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Glenthoj, Andreas" Remove constraint Author: "Glenthoj, Andreas"
83 results on '"Glenthoj, Andreas"'

Search Results

5. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

6. Diagnosis and management of pyruvate kinase deficiency: international expert guidelines

8. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

9. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

11. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective

12. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

13. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

15. Evans syndrome in adults: an observational multicenter study

18. Classification of Α-Thalassemia Data Using Machine Learning Models

20. Molnupiravir Compared to Nirmatrelvir/Ritonavir for COVID-19 in High-Risk Patients with Haematological Malignancy in Europe. A Matched-Paired Analysis from the Epicovideha Registry

21. Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience

25. Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

30. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

31. Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey

32. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

33. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

34. Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

35. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

37. Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses

40. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

41. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

42. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

43. Advances in the laboratory diagnosis of hereditary spherocytosis

50. ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19

Catalog

Books, media, physical & digital resources